Goodness Growth Holdings, Inc.
Goodness Growth Holdings, Inc. (GDNSF) Stock Competitors & Peer Comparison
See (GDNSF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GDNSF | $0.45 | N/A | 61M | -2.66 | -$0.17 | N/A |
| MKKGY | $29.84 | +0.27% | 64.7B | 18.48 | $1.61 | +1.68% |
| MKGAF | $153.14 | +2.29% | 63.3B | 18.08 | $8.05 | +1.72% |
| IPSEY | $46.15 | +0.00% | 61B | 29.02 | $1.59 | +0.86% |
| TKPHF | $37.00 | +0.00% | 58.4B | 80.43 | $0.46 | +3.57% |
| HLNCF | $5.22 | -0.76% | 49.1B | 23.98 | $0.23 | +1.66% |
| SDZNY | $93.50 | +9.43% | 36.7B | 163.67 | $0.52 | +0.85% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $25.94 | -0.23% | 22.1B | 20.27 | $1.28 | +1.70% |
| SGIOY | $11.80 | +0.68% | 19.9B | 17.70 | $0.66 | +1.73% |
Stock Comparison
GDNSF vs MKKGY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, MKKGY has a market cap of 64.7B. Regarding current trading prices, GDNSF is priced at $0.45, while MKKGY trades at $29.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas MKKGY's P/E ratio is 18.48. In terms of profitability, GDNSF's ROE is -0.24%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, GDNSF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check MKKGY's competition here
GDNSF vs MKGAF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, MKGAF has a market cap of 63.3B. Regarding current trading prices, GDNSF is priced at $0.45, while MKGAF trades at $153.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas MKGAF's P/E ratio is 18.08. In terms of profitability, GDNSF's ROE is -0.24%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, GDNSF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check MKGAF's competition here
GDNSF vs IPSEY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, IPSEY has a market cap of 61B. Regarding current trading prices, GDNSF is priced at $0.45, while IPSEY trades at $46.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas IPSEY's P/E ratio is 29.02. In terms of profitability, GDNSF's ROE is -0.24%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, GDNSF and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
GDNSF vs TKPHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TKPHF has a market cap of 58.4B. Regarding current trading prices, GDNSF is priced at $0.45, while TKPHF trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TKPHF's P/E ratio is 80.43. In terms of profitability, GDNSF's ROE is -0.24%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, GDNSF and TKPHF have similar daily volatility (0.00).Check TKPHF's competition here
GDNSF vs HLNCF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HLNCF has a market cap of 49.1B. Regarding current trading prices, GDNSF is priced at $0.45, while HLNCF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HLNCF's P/E ratio is 23.98. In terms of profitability, GDNSF's ROE is -0.24%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, GDNSF and HLNCF have similar daily volatility (0.00).Check HLNCF's competition here
GDNSF vs SDZNY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SDZNY has a market cap of 36.7B. Regarding current trading prices, GDNSF is priced at $0.45, while SDZNY trades at $93.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SDZNY's P/E ratio is 163.67. In terms of profitability, GDNSF's ROE is -0.24%, compared to SDZNY's ROE of +0.02%. Regarding short-term risk, GDNSF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check SDZNY's competition here
GDNSF vs TEVJF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, GDNSF is priced at $0.45, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, GDNSF's ROE is -0.24%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, GDNSF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
GDNSF vs SGIOF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SGIOF has a market cap of 22.1B. Regarding current trading prices, GDNSF is priced at $0.45, while SGIOF trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SGIOF's P/E ratio is 20.27. In terms of profitability, GDNSF's ROE is -0.24%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, GDNSF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check SGIOF's competition here
GDNSF vs SGIOY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SGIOY has a market cap of 19.9B. Regarding current trading prices, GDNSF is priced at $0.45, while SGIOY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SGIOY's P/E ratio is 17.70. In terms of profitability, GDNSF's ROE is -0.24%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, GDNSF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check SGIOY's competition here
GDNSF vs TAIPY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, GDNSF is priced at $0.45, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, GDNSF's ROE is -0.24%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, GDNSF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check TAIPY's competition here
GDNSF vs ESALY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, GDNSF is priced at $0.45, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ESALY's P/E ratio is 20.54. In terms of profitability, GDNSF's ROE is -0.24%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, GDNSF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check ESALY's competition here
GDNSF vs BIOVF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BIOVF has a market cap of 12.8B. Regarding current trading prices, GDNSF is priced at $0.45, while BIOVF trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BIOVF's P/E ratio is 246.67. In terms of profitability, GDNSF's ROE is -0.24%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, GDNSF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
GDNSF vs IPSEF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, GDNSF is priced at $0.45, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, GDNSF's ROE is -0.24%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, GDNSF and IPSEF have similar daily volatility (0.00).Check IPSEF's competition here
GDNSF vs ESALF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ESALF has a market cap of 9.3B. Regarding current trading prices, GDNSF is priced at $0.45, while ESALF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ESALF's P/E ratio is 28.95. In terms of profitability, GDNSF's ROE is -0.24%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, GDNSF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
GDNSF vs ESAIY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ESAIY has a market cap of 9.3B. Regarding current trading prices, GDNSF is priced at $0.45, while ESAIY trades at $8.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ESAIY's P/E ratio is 29.11. In terms of profitability, GDNSF's ROE is -0.24%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, GDNSF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check ESAIY's competition here
GDNSF vs SFOSF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, GDNSF is priced at $0.45, while SFOSF trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SFOSF's P/E ratio is 14.50. In terms of profitability, GDNSF's ROE is -0.24%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, GDNSF and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
GDNSF vs SMDPY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SMDPY has a market cap of 6.1B. Regarding current trading prices, GDNSF is priced at $0.45, while SMDPY trades at $15.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SMDPY's P/E ratio is 6.02. In terms of profitability, GDNSF's ROE is -0.24%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, GDNSF and SMDPY have similar daily volatility (0.00).Check SMDPY's competition here
GDNSF vs LVZPF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, GDNSF is priced at $0.45, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, GDNSF's ROE is -0.24%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, GDNSF and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
GDNSF vs GZPHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, GDNSF is priced at $0.45, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, GDNSF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
GDNSF vs DNPUF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, DNPUF has a market cap of 5.9B. Regarding current trading prices, GDNSF is priced at $0.45, while DNPUF trades at $14.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas DNPUF's P/E ratio is 5.81. In terms of profitability, GDNSF's ROE is -0.24%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, GDNSF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check DNPUF's competition here
GDNSF vs HLUBF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, GDNSF is priced at $0.45, while HLUBF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HLUBF's P/E ratio is 11.43. In terms of profitability, GDNSF's ROE is -0.24%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, GDNSF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
GDNSF vs HLBBF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HLBBF has a market cap of 4.9B. Regarding current trading prices, GDNSF is priced at $0.45, while HLBBF trades at $6.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HLBBF's P/E ratio is 12.17. In terms of profitability, GDNSF's ROE is -0.24%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, GDNSF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
GDNSF vs HKMPF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HKMPF has a market cap of 4.8B. Regarding current trading prices, GDNSF is priced at $0.45, while HKMPF trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HKMPF's P/E ratio is 13.14. In terms of profitability, GDNSF's ROE is -0.24%, compared to HKMPF's ROE of +0.15%. Regarding short-term risk, GDNSF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
GDNSF vs HKMPY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HKMPY has a market cap of 4.8B. Regarding current trading prices, GDNSF is priced at $0.45, while HKMPY trades at $44.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HKMPY's P/E ratio is 13.10. In terms of profitability, GDNSF's ROE is -0.24%, compared to HKMPY's ROE of +0.15%. Regarding short-term risk, GDNSF is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check HKMPY's competition here
GDNSF vs SGFEF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SGFEF has a market cap of 4.6B. Regarding current trading prices, GDNSF is priced at $0.45, while SGFEF trades at $104.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SGFEF's P/E ratio is 23.51. In terms of profitability, GDNSF's ROE is -0.24%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, GDNSF and SGFEF have similar daily volatility (0.00).Check SGFEF's competition here
GDNSF vs APNHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, GDNSF is priced at $0.45, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas APNHF's P/E ratio is -54.67. In terms of profitability, GDNSF's ROE is -0.24%, compared to APNHF's ROE of -0.01%. Regarding short-term risk, GDNSF and APNHF have similar daily volatility (0.00).Check APNHF's competition here
GDNSF vs APNHY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, APNHY has a market cap of 3.6B. Regarding current trading prices, GDNSF is priced at $0.45, while APNHY trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas APNHY's P/E ratio is -53.67. In terms of profitability, GDNSF's ROE is -0.24%, compared to APNHY's ROE of -0.01%. Regarding short-term risk, GDNSF and APNHY have similar daily volatility (0.00).Check APNHY's competition here
GDNSF vs LBTSF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, GDNSF is priced at $0.45, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LBTSF's P/E ratio is 66.74. In terms of profitability, GDNSF's ROE is -0.24%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, GDNSF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
GDNSF vs CHSYF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, GDNSF is priced at $0.45, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, GDNSF's ROE is -0.24%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, GDNSF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
GDNSF vs ULIHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, GDNSF is priced at $0.45, while ULIHF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ULIHF's P/E ratio is 6.67. In terms of profitability, GDNSF's ROE is -0.24%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, GDNSF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
GDNSF vs INVVY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, GDNSF is priced at $0.45, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas INVVY's P/E ratio is -62.42. In terms of profitability, GDNSF's ROE is -0.24%, compared to INVVY's ROE of -0.60%. Regarding short-term risk, GDNSF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
GDNSF vs IZQVF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, GDNSF is priced at $0.45, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, GDNSF's ROE is -0.24%, compared to IZQVF's ROE of -0.60%. Regarding short-term risk, GDNSF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
GDNSF vs HYPMY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HYPMY has a market cap of 2.8B. Regarding current trading prices, GDNSF is priced at $0.45, while HYPMY trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HYPMY's P/E ratio is 17.52. In terms of profitability, GDNSF's ROE is -0.24%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, GDNSF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check HYPMY's competition here
GDNSF vs HMDCF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HMDCF has a market cap of 2.6B. Regarding current trading prices, GDNSF is priced at $0.45, while HMDCF trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HMDCF's P/E ratio is 5.70. In terms of profitability, GDNSF's ROE is -0.24%, compared to HMDCF's ROE of +0.47%. Regarding short-term risk, GDNSF and HMDCF have similar daily volatility (0.00).Check HMDCF's competition here
GDNSF vs NPPNY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, GDNSF is priced at $0.45, while NPPNY trades at $8.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NPPNY's P/E ratio is 10.92. In terms of profitability, GDNSF's ROE is -0.24%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, GDNSF and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
GDNSF vs DMPHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, GDNSF is priced at $0.45, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, GDNSF's ROE is -0.24%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, GDNSF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
GDNSF vs NPNKF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, GDNSF is priced at $0.45, while NPNKF trades at $30.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NPNKF's P/E ratio is 9.94. In terms of profitability, GDNSF's ROE is -0.24%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, GDNSF and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
GDNSF vs HTSUF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, GDNSF is priced at $0.45, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, GDNSF's ROE is -0.24%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, GDNSF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
GDNSF vs ARSUF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, GDNSF is priced at $0.45, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ARSUF's P/E ratio is 19.42. In terms of profitability, GDNSF's ROE is -0.24%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, GDNSF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
GDNSF vs DUTV Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, GDNSF is priced at $0.45, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas DUTV's P/E ratio is N/A. In terms of profitability, GDNSF's ROE is -0.24%, compared to DUTV's ROE of -0.05%. Regarding short-term risk, GDNSF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check DUTV's competition here
GDNSF vs CURLF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CURLF has a market cap of 1.9B. Regarding current trading prices, GDNSF is priced at $0.45, while CURLF trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CURLF's P/E ratio is -6.86. In terms of profitability, GDNSF's ROE is -0.24%, compared to CURLF's ROE of -0.31%. Regarding short-term risk, GDNSF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check CURLF's competition here
GDNSF vs TSMRF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, GDNSF is priced at $0.45, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, GDNSF's ROE is -0.24%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, GDNSF and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
GDNSF vs MITPF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, GDNSF is priced at $0.45, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas MITPF's P/E ratio is -10.81. In terms of profitability, GDNSF's ROE is -0.24%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, GDNSF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check MITPF's competition here
GDNSF vs SHPHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SHPHF has a market cap of 1.6B. Regarding current trading prices, GDNSF is priced at $0.45, while SHPHF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SHPHF's P/E ratio is -5.67. In terms of profitability, GDNSF's ROE is -0.24%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, GDNSF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
GDNSF vs GTBIF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, GDNSF is priced at $0.45, while GTBIF trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GTBIF's P/E ratio is 39.35. In terms of profitability, GDNSF's ROE is -0.24%, compared to GTBIF's ROE of +0.02%. Regarding short-term risk, GDNSF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check GTBIF's competition here
GDNSF vs KARBF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, GDNSF is priced at $0.45, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KARBF's P/E ratio is 262.50. In terms of profitability, GDNSF's ROE is -0.24%, compared to KARBF's ROE of N/A. Regarding short-term risk, GDNSF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
GDNSF vs EVOTF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, EVOTF has a market cap of 1.4B. Regarding current trading prices, GDNSF is priced at $0.45, while EVOTF trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas EVOTF's P/E ratio is -7.42. In terms of profitability, GDNSF's ROE is -0.24%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, GDNSF and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
GDNSF vs CHIZF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, GDNSF is priced at $0.45, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, GDNSF's ROE is -0.24%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, GDNSF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
GDNSF vs SWGHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, GDNSF is priced at $0.45, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, GDNSF's ROE is -0.24%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, GDNSF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
GDNSF vs CASBF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, GDNSF is priced at $0.45, while CASBF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CASBF's P/E ratio is -37.50. In terms of profitability, GDNSF's ROE is -0.24%, compared to CASBF's ROE of -0.03%. Regarding short-term risk, GDNSF and CASBF have similar daily volatility (0.00).Check CASBF's competition here
GDNSF vs TCNNF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, GDNSF is priced at $0.45, while TCNNF trades at $6.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TCNNF's P/E ratio is -10.32. In terms of profitability, GDNSF's ROE is -0.24%, compared to TCNNF's ROE of -0.11%. Regarding short-term risk, GDNSF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check TCNNF's competition here
GDNSF vs LJUIF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, GDNSF is priced at $0.45, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, GDNSF's ROE is -0.24%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, GDNSF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
GDNSF vs KSPHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, GDNSF is priced at $0.45, while KSPHF trades at $26.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KSPHF's P/E ratio is 12.04. In terms of profitability, GDNSF's ROE is -0.24%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, GDNSF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
GDNSF vs BIOGY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, GDNSF is priced at $0.45, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, GDNSF's ROE is -0.24%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, GDNSF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
GDNSF vs GNMLF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GNMLF has a market cap of 1B. Regarding current trading prices, GDNSF is priced at $0.45, while GNMLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GNMLF's P/E ratio is 10.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to GNMLF's ROE of +0.13%. Regarding short-term risk, GDNSF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
GDNSF vs KKPCF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, GDNSF is priced at $0.45, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, GDNSF's ROE is -0.24%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, GDNSF and KKPCF have similar daily volatility (0.00).Check KKPCF's competition here
GDNSF vs TWAPF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, GDNSF is priced at $0.45, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, GDNSF's ROE is -0.24%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, GDNSF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
GDNSF vs NIKA Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, GDNSF is priced at $0.45, while NIKA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NIKA's P/E ratio is N/A. In terms of profitability, GDNSF's ROE is -0.24%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, GDNSF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
GDNSF vs CSWYF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, GDNSF is priced at $0.45, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, GDNSF's ROE is -0.24%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, GDNSF and CSWYF have similar daily volatility (0.00).Check CSWYF's competition here
GDNSF vs TRXPF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, GDNSF is priced at $0.45, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, GDNSF's ROE is -0.24%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, GDNSF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
GDNSF vs SHEZF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, GDNSF is priced at $0.45, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, GDNSF's ROE is -0.24%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, GDNSF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
GDNSF vs YIHCF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, GDNSF is priced at $0.45, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, GDNSF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
GDNSF vs GLASF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GLASF has a market cap of 630.7M. Regarding current trading prices, GDNSF is priced at $0.45, while GLASF trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GLASF's P/E ratio is -38.86. In terms of profitability, GDNSF's ROE is -0.24%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, GDNSF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check GLASF's competition here
GDNSF vs AIHLF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, GDNSF is priced at $0.45, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, GDNSF's ROE is -0.24%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, GDNSF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
GDNSF vs TRSSF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, GDNSF is priced at $0.45, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, GDNSF's ROE is -0.24%, compared to TRSSF's ROE of -0.85%. Regarding short-term risk, GDNSF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check TRSSF's competition here
GDNSF vs PKBFF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, GDNSF is priced at $0.45, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PKBFF's P/E ratio is N/A. In terms of profitability, GDNSF's ROE is -0.24%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, GDNSF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
GDNSF vs CCHWF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, GDNSF is priced at $0.45, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, GDNSF's ROE is -0.24%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, GDNSF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check CCHWF's competition here
GDNSF vs BOIRF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, GDNSF is priced at $0.45, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, GDNSF's ROE is -0.24%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, GDNSF and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
GDNSF vs AGYTF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, GDNSF is priced at $0.45, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, GDNSF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
GDNSF vs KHTRF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, KHTRF has a market cap of 474.3M. Regarding current trading prices, GDNSF is priced at $0.45, while KHTRF trades at $4.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas KHTRF's P/E ratio is -157.43. In terms of profitability, GDNSF's ROE is -0.24%, compared to KHTRF's ROE of -0.00%. Regarding short-term risk, GDNSF and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
GDNSF vs PEXXF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, GDNSF is priced at $0.45, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to PEXXF's ROE of N/A. Regarding short-term risk, GDNSF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
GDNSF vs SWDCF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SWDCF has a market cap of 443.7M. Regarding current trading prices, GDNSF is priced at $0.45, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SWDCF's P/E ratio is 69.40. In terms of profitability, GDNSF's ROE is -0.24%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, GDNSF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
GDNSF vs ELTP Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ELTP has a market cap of 426M. Regarding current trading prices, GDNSF is priced at $0.45, while ELTP trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ELTP's P/E ratio is 19.83. In terms of profitability, GDNSF's ROE is -0.24%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, GDNSF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check ELTP's competition here
GDNSF vs HUMDF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HUMDF has a market cap of 405.4M. Regarding current trading prices, GDNSF is priced at $0.45, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HUMDF's P/E ratio is 2.74. In terms of profitability, GDNSF's ROE is -0.24%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, GDNSF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
GDNSF vs VRNOF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, VRNOF has a market cap of 358.2M. Regarding current trading prices, GDNSF is priced at $0.45, while VRNOF trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas VRNOF's P/E ratio is -1.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to VRNOF's ROE of -0.52%. Regarding short-term risk, GDNSF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check VRNOF's competition here
GDNSF vs CRLBF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CRLBF has a market cap of 346.1M. Regarding current trading prices, GDNSF is priced at $0.45, while CRLBF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CRLBF's P/E ratio is -6.35. In terms of profitability, GDNSF's ROE is -0.24%, compared to CRLBF's ROE of -0.12%. Regarding short-term risk, GDNSF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check CRLBF's competition here
GDNSF vs CPHRF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CPHRF has a market cap of 285M. Regarding current trading prices, GDNSF is priced at $0.45, while CPHRF trades at $11.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CPHRF's P/E ratio is 16.77. In terms of profitability, GDNSF's ROE is -0.24%, compared to CPHRF's ROE of +0.16%. Regarding short-term risk, GDNSF and CPHRF have similar daily volatility (0.00).Check CPHRF's competition here
GDNSF vs BHCCF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, GDNSF is priced at $0.45, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, GDNSF's ROE is -0.24%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, GDNSF and BHCCF have similar daily volatility (0.00).Check BHCCF's competition here
GDNSF vs PLNHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, GDNSF is priced at $0.45, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, GDNSF's ROE is -0.24%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, GDNSF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check PLNHF's competition here
GDNSF vs PHCUF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, GDNSF is priced at $0.45, while PHCUF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PHCUF's P/E ratio is 700.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, GDNSF and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
GDNSF vs SHIEF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, GDNSF is priced at $0.45, while SHIEF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, GDNSF's ROE is -0.24%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, GDNSF and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here
GDNSF vs COPHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, GDNSF is priced at $0.45, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas COPHF's P/E ratio is -0.02. In terms of profitability, GDNSF's ROE is -0.24%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, GDNSF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check COPHF's competition here
GDNSF vs BIOYF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, BIOYF has a market cap of 127.7M. Regarding current trading prices, GDNSF is priced at $0.45, while BIOYF trades at $11.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas BIOYF's P/E ratio is 20.62. In terms of profitability, GDNSF's ROE is -0.24%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, GDNSF is less volatile compared to BIOYF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check BIOYF's competition here
GDNSF vs LOVFF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LOVFF has a market cap of 124.1M. Regarding current trading prices, GDNSF is priced at $0.45, while LOVFF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LOVFF's P/E ratio is 14.40. In terms of profitability, GDNSF's ROE is -0.24%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, GDNSF and LOVFF have similar daily volatility (0.00).Check LOVFF's competition here
GDNSF vs NWPN Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, GDNSF is priced at $0.45, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas NWPN's P/E ratio is -0.04. In terms of profitability, GDNSF's ROE is -0.24%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, GDNSF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check NWPN's competition here
GDNSF vs CBWTF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CBWTF has a market cap of 121.4M. Regarding current trading prices, GDNSF is priced at $0.45, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CBWTF's P/E ratio is 3.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, GDNSF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check CBWTF's competition here
GDNSF vs LPCUF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, GDNSF is priced at $0.45, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, GDNSF's ROE is -0.24%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, GDNSF and LPCUF have similar daily volatility (0.00).Check LPCUF's competition here
GDNSF vs AAWH Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, AAWH has a market cap of 111.7M. Regarding current trading prices, GDNSF is priced at $0.45, while AAWH trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas AAWH's P/E ratio is -1.31. In terms of profitability, GDNSF's ROE is -0.24%, compared to AAWH's ROE of -2.27%. Regarding short-term risk, GDNSF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check AAWH's competition here
GDNSF vs CWBHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CWBHF has a market cap of 111.6M. Regarding current trading prices, GDNSF is priced at $0.45, while CWBHF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CWBHF's P/E ratio is -5.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, GDNSF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check CWBHF's competition here
GDNSF vs ORXOF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ORXOF has a market cap of 111.5M. Regarding current trading prices, GDNSF is priced at $0.45, while ORXOF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ORXOF's P/E ratio is -2.48. In terms of profitability, GDNSF's ROE is -0.24%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, GDNSF and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
GDNSF vs CNVCF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, GDNSF is priced at $0.45, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, GDNSF and CNVCF have similar daily volatility (0.00).Check CNVCF's competition here
GDNSF vs HLTRF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, HLTRF has a market cap of 105.1M. Regarding current trading prices, GDNSF is priced at $0.45, while HLTRF trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas HLTRF's P/E ratio is -7.47. In terms of profitability, GDNSF's ROE is -0.24%, compared to HLTRF's ROE of -0.21%. Regarding short-term risk, GDNSF and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
GDNSF vs JUSHF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, JUSHF has a market cap of 103.8M. Regarding current trading prices, GDNSF is priced at $0.45, while JUSHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas JUSHF's P/E ratio is -1.60. In terms of profitability, GDNSF's ROE is -0.24%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, GDNSF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check JUSHF's competition here
GDNSF vs ORXOY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ORXOY has a market cap of 102.7M. Regarding current trading prices, GDNSF is priced at $0.45, while ORXOY trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ORXOY's P/E ratio is -2.28. In terms of profitability, GDNSF's ROE is -0.24%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, GDNSF and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here
GDNSF vs ABSCF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, GDNSF is priced at $0.45, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas ABSCF's P/E ratio is -8.06. In terms of profitability, GDNSF's ROE is -0.24%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, GDNSF and ABSCF have similar daily volatility (0.00).Check ABSCF's competition here
GDNSF vs GRUSF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, GRUSF has a market cap of 93.2M. Regarding current trading prices, GDNSF is priced at $0.45, while GRUSF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas GRUSF's P/E ratio is 12.44. In terms of profitability, GDNSF's ROE is -0.24%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, GDNSF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check GRUSF's competition here
GDNSF vs EOFBY Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, GDNSF is priced at $0.45, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, GDNSF's ROE is -0.24%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, GDNSF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
GDNSF vs MEDXF Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, MEDXF has a market cap of 66.8M. Regarding current trading prices, GDNSF is priced at $0.45, while MEDXF trades at $2.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas MEDXF's P/E ratio is -103.00. In terms of profitability, GDNSF's ROE is -0.24%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, GDNSF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check MEDXF's competition here
GDNSF vs PLNH Comparison February 2026
GDNSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDNSF stands at 61M. In comparison, PLNH has a market cap of 56.6M. Regarding current trading prices, GDNSF is priced at $0.45, while PLNH trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDNSF currently has a P/E ratio of -2.66, whereas PLNH's P/E ratio is -0.67. In terms of profitability, GDNSF's ROE is -0.24%, compared to PLNH's ROE of -0.91%. Regarding short-term risk, GDNSF is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for GDNSF.Check PLNH's competition here